Skip to content
Medical Health Aged Care

Most Australian hospitals are able to offer good stroke care, but many patients are missing out

The Florey 4 mins read

A new report across six states and territories shows data from the Australian Stroke Clinical Registry (AuSCR) is improving clinical outcomes for patients with stroke, with two leading hospitals achieving marked improvements over a short time. 

The heartening results show the power of registries and while some centres are making progress, there is still more to be done to ensure patients get the same level of care no matter where they are across the country.  

Stroke is a leading cause of death in Australia, claiming more than 8000 lives a year. Although fatality rates for stroke have been declining since 1980, thanks to factors such as reduced tobacco smoking rates and specialised stroke units, data shows many aspects of care still need to improve. 

AuSCR’s latest Annual Report shows stroke care is not provided equally across the country and not all patients are accessing stroke units - the cornerstone of best practice. 

The AuSCR, which helps hospitals pinpoint areas for improvement, is led by The Florey, with consortium partners the Stroke Foundation, Australian and New Zealand Stroke Organisation and Monash University.  

AuSCR Data Custodian at The Florey, Professor Dominique Cadilhac said: “Our registry data shows patients treated in a stroke unit have 44–63 per cent improved survival within six months. But in 2022, a quarter of patients with stroke were not treated in one of these units.” 

Professor Cadilhac said AuSCR’s 2022 Annual Report included new, ambitious national targets, set by leading organisations including the Stroke Foundation and Australian and New Zealand Stroke Organisation. 

“These targets are designed to improve access to life-saving stroke care in Australia by 2030, including in rural and remote areas. 

“One target, in line with international best practice, is to treat people eligible for clot-busting treatments within 60 minutes of arrival to hospital. But our data shows that last year only five of our 61 Australian participating hospitals were able to meet this target with at least half of their patients,” Professor Cadilhac. 

Professor Helen Dewey, Clinical Director of Neurosciences at Eastern Health and AuSCR’s Management Committee Chair, said the registry played a vital role in monitoring progress and supporting governments and hospitals to improve their stroke care. 

“We want hospitals to use the new targets and latest data to pinpoint areas for improvement. We’ve already seen examples of The Alfred and Redcliffe Hospitals using our data to make 

simple changes that improved access to treatments that can improve health outcomes for their patients,” Professor Dewey said. 

The Alfred, Victoria 

Professor Geoffrey Cloud, Director of Stroke Services at The Alfred said 2021 AuSCR data showed the hospital was below average for prescribing targeted life-saving prevention medications to stroke patients on discharge. 

“The solution was to give pharmacists a more prominent role, including having them join the stroke ward rounds where they were empowered to take a more proactive approach.” 

The Alfred also asked pharmacists to educate new nurses, doctors and new pharmacists on the stroke ward, and added a reminder about secondary stroke prevention medications into each discharge summary. 

“One year later, after making those small changes, I’m pleased to say we’re above the benchmark for prescribing antihypertensive and antithrombotic medications, and above the national average for lipid-lowering medications," Professor Cloud said. 

Redcliffe Hospital, Queensland 

At Redcliffe Hospital, 2021 AuSCR data identified that only 55 per cent of patients in 2021 received a discharge care plan. The hospital increased this to 82 per cent by educating staff about the hospital’s stroke nurse navigator and the importance of care plans. 

 New National Stroke Targets 


Quality indicator 


National stroke target 


National performance (2022) 


Hospitals achieving target^ 


Endovascular clot retrieval door-to-puncture time for transfers* 


<30 minutes 


40 minutes 




Thrombolysis door-to-needle time*# 


<60 minutes 


74 minutes 




Endovascular clot retrieval door-in-door-out time* (optional emergency department dataset) 


<60 minutes  

(Metropolitan and inner regional hospitals) 


120 minutes 




<75 minutes (Outer reginal road retrievals) 


234 minutes 




Endovascular clot retrieval door-to-puncture time for primary presenters* 


<90 minutes 


115 minutes 




Patients with a primary stroke diagnosis receiving certified stroke unit care 


>90 per cent 


75 per cent 



Includes adult episodes only 

* Includes only ischaemic stroke 

# Excludes transfers and in-hospital stroke 

^ Of the eligible hospitals providing this indicator. Excludes hospitals with fewer than 10 eligible episodes 


Key Facts:

In 2022 AuSCR gathered data for more than 17,000 episodes of acute stroke from 61 hospitals in six states and territories. The data represents at least 75 per cent of hospitals from ACT, Queensland, Tasmania and Victoria, and nearly half of all patients admitted to hospitals with stroke in Australia. It includes: 

  • * One in three stroke patients are treated with thrombolysis (clot busting medication) within the recommended one hour of arrival to hospital 

  • * Stroke unit care was associated with 44–63 per cent improved survival for patients within six months 

  • One in five stroke patients reported being readmitted to hospital 

  • * One in three stroke patients report moderate to severe disability 

  • * Half reported problems with mood, mobility, pain or usual activities

About us:

Find out more about us on our website: 

Contact details:

Kathryn Powley, Media and Communications Manager | 0456 666 271 

More from this category

  • Government NSW, Medical Health Aged Care
  • 12/07/2024
  • 12:39
MEDIA RELEASE - Network of Alcohol & Other Drug Agencies


12 July 2024 The forthcoming NSW Drug Summit is an opportunity to shelve outdated drug policies that have failed to deliver better health andwellbeing outcomes for individuals and their families. That’s the verdict from the peak organisation for the non-government drug and alcohol sector in NSW, the Network of Alcohol and other Drugs Agencies (NADA). NADA today welcomed the Government’s confirmation the NSW Drug Summit will be held over two days in regional NSW in October, and in Sydney on 4th and 5th December, as well as consultations about the Terms of Reference and other matters ahead of this. NADA…

  • Contains:
  • Medical Health Aged Care
  • 12/07/2024
  • 09:00
National Hypertension Taskforce - Australian Cardiovascular Alliance and Hypertension Australia

Australian Hypertension Taskforce unveils Roadmap to transform high blood pressure control and reduce preventable deaths

Raised blood pressure (BP), also known as hypertension, is a ‘silent killer’ and the leading cause of death in Australia, where it contributes to more than 25,000 deaths each year. It is also the leading risk factor for death from stroke, heart disease, kidney disease, and dementia, yet 68% of Australians with hypertension are uncontrolled. In response to this pressing issue, a Call to Action was published in 2022, leading to the establishment of the National Hypertension Taskforce, launched by Mark Butler MP, Minister for Health and Aged Care. The National Hypertension Taskforce, led by the Australian Cardiovascular Alliance and…

  • Medical Health Aged Care
  • 12/07/2024
  • 00:11
AI Medi Scan

AI Medi Scan Introduces New At-Home Skin Cancer Detection Technology

AI Medi Scan is developing a device that uses artificial intelligence (AI) and fluorescence imaging to allow Australians to conduct skin cancer checks at home, aiming to alleviate the impact of dermatologist shortages.SYDNEY, July 12, 2024 (GLOBE NEWSWIRE) -- AI Medi Scan, an Australian company, is pioneering a shift in skin cancer detection with its ongoing development of advanced diagnostic technologies. Aimed at empowering individuals and integrating with broader healthcare services, AI Medi Scan's long-term goal is to revolutionise how Australians address skin health, particularly in detecting melanoma, a prevalent cancer in the region.The company's current R&D efforts are focused…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.